Cite
Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.
MLA
Seo, Mikyung Kelly, and John Cairns. “Do Cancer Biomarkers Make Targeted Therapies Cost-Effective? A Systematic Review in Metastatic Colorectal Cancer.” PLoS ONE, vol. 13, no. 9, Sept. 2018, pp. 1–23. EBSCOhost, https://doi.org/10.1371/journal.pone.0204496.
APA
Seo, M. K., & Cairns, J. (2018). Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer. PLoS ONE, 13(9), 1–23. https://doi.org/10.1371/journal.pone.0204496
Chicago
Seo, Mikyung Kelly, and John Cairns. 2018. “Do Cancer Biomarkers Make Targeted Therapies Cost-Effective? A Systematic Review in Metastatic Colorectal Cancer.” PLoS ONE 13 (9): 1–23. doi:10.1371/journal.pone.0204496.